【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 9
2 Introduction 10
2.1 What Is This Report About? 10
3 Definitions of Markets/Categories Covered 11
3.1 Endoscopy Devices 11
3.1.1 Capsule Endoscope Systems 11
4 Company Snapshot 12
4.1 Key Facts 12
4.2 Company Overview 12
4.3 Financial Performance 12
4.4 SWOT Snapshot 12
4.5 Business Overview 13
4.6 Major Products and Services 14
4.6.1 Overview 14
5 History 15
6 SWOT Analysis 17
6.1 Overview 17
6.2 Given Imaging Ltd. Strengths 18
6.2.1 Focused R&D Activities 18
6.2.2 Broad Product Range 18
6.2.3 Diversified Geographical Presence 18
6.3 Given Imaging Ltd. Weaknesses 19
6.3.1 Dependence on Single Source Suppliers 19
6.4 Given Imaging Ltd. Opportunities 19
6.4.1 Global Endoscopy Devices Market 19
6.4.2 Product Launches and Approvals 19
6.4.3 Growing Aged Population 20
6.4.4 Inorganic Growth Drivers: Acquisitions 20
6.5 Given Imaging Ltd. Threats 21
6.5.1 Rapid Technological Change 21
6.5.2 Healthcare Reform Bill 21
6.5.3 Changing Diagnostic Market Conditions 21
6.5.4 Competitive Landscape 21
7 Competitors 22
8 Competitive Landscape 23
8.1 Endoscopy Devices (Capsule Endoscope Systems), Global, Market Share (%), 2012 23
8.2 Given Imaging Ltd., Endoscopy Devices (Capsule Endoscope Systems), by Region, Market Share (2012) 24
8.3 Given Imaging Ltd., Endoscopy Devices (Capsule Endoscope Systems), by Country, Market Share (2012) 25
9 Key Employees 27
10 Key Employee Biographies 28
11 Company Statement 30
12 Locations And Subsidiaries 32
12.1 Head Office 32
12.2 Other Locations & Subsidiaries 32
13 Financial Deals Landscape 33
13.1 Given Imaging Ltd., Deals Volume Summary, 2007 to 2013 33
14 Given Imaging Ltd. Detailed Deal Summary 35
14.1 Asset Purchase 35
14.1.1 Given Imaging Acquires SmartPill GI Monitoring Assets From SmartPill For $6 Million 35
14.1.2 Given Imaging Acquires Bravo Monitoring Business From Medtronic 37
14.2 Partnerships 39
14.2.1 Given Imaging Expands Its Distribution Agreement with FUJIFILM 39
14.2.2 Given Imaging And Fujinon Corporation Sign Global Strategic Collaboration 40
14.3 Equity Offering 41
14.3.1 Given Imaging Completes Private Placement Of $5.2 Million 41
14.4 Acquisition 42
14.4.1 Given Imaging Completes Acquisition Of Sierra Scientific Instruments From Water Street Healthcare Partners 42
14.4.2 Alpine Biomed Acquires Sierra Scientific Instruments 44
14.4.3 Elron Electronic Acquires Minority Stake In Given Imaging 45
15 Recent Developments 47
15.1 Financial Announcements 47
15.1.1 Feb 12, 2013: Given Imaging Reports Revenue Of $180.5m In 2012 47
15.1.2 Nov 06, 2012: Given Imaging Reports Revenue Of $45.4m In Q3 2012 49
15.1.3 Aug 07, 2012: Given Imaging Reports Revenue Of $44.5m In Q2 2012 50
15.1.4 May 08, 2012: Given Imaging Reports Revenue Of $41.8m In Q1 2012 51
15.1.5 Feb 14, 2012: Given Imaging Reports Revenue Of $178m In 2011 52
15.1.6 Nov 01, 2011: Given Imaging Reports Revenues Of $44.7m In Q3 2011 54
15.1.7 Aug 03, 2011: Given Imaging Reports Revenues Of $44.8m In Q2 2011 55
15.1.8 May 04, 2011: Given Imaging Reports Revenues Of $40m In Q1 2011 56
15.1.9 Feb 15, 2011: Given Imaging Reports Revenues Of $157.8m In 2010 57
15.1.10 Nov 03, 2010: Given Imaging Reports Revenues Of $38.65 Million In Q3 2010 58
15.1.11 Aug 11, 2010: Given Imaging Reports Net Profit Of $2.21 Million In Q2 2010 59
15.1.12 May 11, 2010: Given Imaging Reports Revenues Of $32.1 Million In Q1 2010 60
15.1.13 Feb 16, 2010: Given Imaging Reports Revenues Of $141.8 Million For 2009 61
15.1.14 Nov 04, 2009: Given Imaging Reports Net Profit Of $3.7 Million In Q3 2009 62
15.1.15 Aug 05, 2009: Given Imaging Reports Net Profit Of $4.6 Million In Q2 2009 63
15.1.16 May 06, 2009: Given Imaging Revenues Increases By 12% In Q1 2009 65
15.1.17 Feb 10, 2009: Given Imaging Declares Special Cash Dividend 66
15.1.18 Feb 10, 2009: Given Imaging Reports 2008 Results 66
15.1.19 Jan 19, 2009: Given Imaging To Declare 2008 Results 67
15.1.20 Nov 11, 2008: Given Imaging Reports 3Q 2008 Results 68
15.1.21 Aug 06, 2008: Given Imaging Reports 2Q 2008 Results 69
15.1.22 May 13, 2008: Given Imaging Declares Q1 2008 Results 70
15.1.23 Apr 22, 2008: Given Imaging To Declare Q1 2008 Results 71
15.1.24 Feb 20, 2008: Given Imaging Declares Q4 2007 Results 71
15.1.25 Oct 30, 2007: Given Imaging Reports Q3 2007 Results 72
15.1.26 Aug 01, 2007: Given Imaging Reports Q2 2007 Results 72
15.1.27 May 07, 2007: Given Imaging Declares Q1 2007 Results 73
15.2 Research And Development 73
15.2.1 Oct 25, 2010: Given Imaging Announces New Data Showing PillCam SB To Be Accurate Tool To Evaluate Patients With Crohn’s Disease, Functional GI Disorders And OGIB 73
15.3 Corporate Communications 75
15.3.1 Sep 25, 2008: Given Imaging CFO To Present At The JMP Securities And Maxim Group Growth Confrences 75
15.3.2 Sep 03, 2008: Given Imaging’s CEO To Present At The Morgan Stanley Conference 75
15.4 Legal and Regulatory 75
15.4.1 Jul 09, 2012: Korea Intellectual Property Tribunal Holds Given Imaging Patents Valid 75
15.4.2 Nov 30, 2011: Given Imaging Files Patent Infringement Lawsuit In Korea Against Intromedic 76
15.4.3 Mar 21, 2011: Given Imaging Wins Patent Infringement Lawsuit Against IntroMedic In Germany 76
15.4.4 Jun 17, 2008: Given Imaging Completes Patent Litigation Settlement With Olympus 77
15.5 Product News 77
15.5.1 Jan 03, 2013: Given Imaging Launches ManoView ESO v3.0 Software 77
15.5.2 Nov 27, 2012: Given Imaging Submits PillCam Colon 2 Application To FDA For US Regulatory Clearance 77
15.5.3 Oct 22, 2012: Given Imaging Announces New Studies Highlighting Diverse Applications Of ManoScan At ACG 2012 Annual Meeting 78
15.5.4 Oct 22, 2012: Given Imaging Reports New Studies On PillCam Colon 2 Presented At UEG Week In Amsterdam 79
15.5.5 Oct 21, 2012: Given Imaging Announces Data At UEG Week Confirms PillCam SB’s Role As Diagnostic Gold-Standard For Small Bowel Diseases 80
15.5.6 Sep 19, 2012: Given Imaging Submits PillCam Colon 2 Pivotal Trial Data To Japan’s PMDA For Approval 81
15.5.7 Aug 07, 2012: Given Imaging Expects To Receive FDA And PMDA Approvals For PillCam COLON 2 82
15.5.8 Jul 11, 2012: Given Imaging Announces Reimbursement In Japan For Expanded PillCam SB Indications 82
15.5.9 May 22, 2012: Given Imaging Announces Significant New Data On PillCam SB At DDW 83
15.5.10 May 22, 2012: New Studies Confirm Given Imaging’s PillCam COLON 2’s Feasibility In An Outpatient Setting 84
15.5.11 May 22, 2012: New Studies Confirm Value Of Given Imaging’s PillCam SB In Managing Pediatric Patients With Inflammatory Bowel Disease 85
15.5.12 May 20, 2012: Data Show That Capsule Endoscopy Correlates With Gastroscopy Findings: Given Imaging 85
15.5.13 May 20, 2012: Study Shows That Bravo pH Monitoring Can Be Successfully Extended In Most Cases: Given Imaging 87
15.5.14 Mar 27, 2012: Given Imaging Receives Clearance For Expanded PillCam SB Indications In Japan 88
15.5.15 Mar 12, 2012: Given Imaging Announces Publication Of Colon Capsule Endoscopy Guidelines In Endoscopy 89
15.5.16 Jan 04, 2012: Given Imaging Provides Update On PillCam COLON 2 Pivotal Trial Enrollment 90
15.5.17 Nov 15, 2011: Given Imaging Initiates Pivotal Trial For PillCam COLON 2 In Japan 90
15.5.18 Nov 02, 2011: Given Imaging Announces New Studies Highlighting Value Of ManoScan AR In Patients With Incontinence 91
15.5.19 Nov 02, 2011: New Studies Confirm Use Of Bravo Wireless pH Monitoring For Assessment Of GERD: Given Imaging 92
15.5.20 Oct 31, 2011: Given Imaging Announces New Studies Validate Use Of PillCam SB To Detect And Monitor Crohn’s Disease 93
15.5.21 Oct 25, 2011: Given Imaging Announces New Studies Highlighting Value Of ManoScan High Resolution Manometry Testing For Conditions Resulting From Anti-Reflux Surgery 94
15.5.22 Oct 25, 2011: Given Imaging Announces New Studies Showing PillCam SB Can Detect And Monitor Small Bowel Crohn’s Disease 95
15.5.23 Oct 25, 2011: Given Imaging Announces Results From Multiple PillCam COLON Studies Presented At UEGW 2011 96
15.5.24 Oct 18, 2011: Given Imaging Announces New Study Shows Impact Of PillCam SB On Management Of Symptomatic IBD Cases 96
15.5.25 Sep 26, 2011: Given Imaging Announces Positive Data Published In Gastrointestinal Endoscopy Featuring Second-Generation PillCam COLON 97
15.5.26 Jun 06, 2011: Given Imaging Initiates Trial For PillCam COLON 2 Capsule Endoscopy 98
15.5.27 May 23, 2011: Given Imaging Receives FDA Clearance For PillCam ESO 3 99
15.5.28 May 11, 2011: Given Imaging Announces Positive Results From European Multicenter Study Of PillCam COLON 2 99
15.5.29 May 10, 2011: Given Imaging Announces New Clinical Studies Recommend Increased Use Of ManoScan High Resolution Manometry To Diagnose Motility Disorders 101
15.5.30 May 10, 2011: Given Imaging Announces New Presentations Emphasize Value Of PillCam Capsule Endoscopy In Patients With Gastrointestinal Bleeding At Digestive Disease Week 2011 102
15.5.31 May 09, 2011: Given Imaging Announces New Data On Benefits Of Using Bravo Wireless pH Monitoring To Manage GERD 103
15.5.32 May 09, 2011: Given Imaging Announces New Studies Confirm PillCam SB’s Role In Management Of Patients With Suspected And Known Crohn’s Disease 104
15.5.33 Mar 10, 2011: Given Imaging Unveils Updated FDA Clearance For PillCam SB Video Capsule 105
15.5.34 Jan 05, 2011: Given Imaging Initiates Study In US For PillCam COLON 2 Capsule Endoscopy 106
15.5.35 Dec 21, 2010: Given Imaging Receives Reimbursement Code From Brazilian Medical Association For PillCam SB Capsule Endoscopy 106
15.5.36 Apr 29, 2010: Given Imaging Introduces RAPID pH Software And PillCam Express 107
15.5.37 Apr 19, 2010: Given Imaging To Complete RD-300 Trial For PillCam Express Capsule Endoscopy Delivery System In Second Quarter Of 2010 108
15.5.38 Apr 13, 2010: Given Imaging To Complete Phase III Trial For PillCam COLON 2 In First Half Of 2010 108
15.5.39 Apr 12, 2010: Given Imaging To Complete Phase I Trial For PillCam SB2 Capsule In First Quarter Of 2011 108
15.6 Product Approvals 109
15.6.1 Aug 07, 2012: Given Imaging Expects To Receive FDA And PMDA Approvals For PillCam COLON 2 109
15.6.2 Mar 27, 2012: Given Imaging Receives Clearance For Expanded PillCam SB Indications In Japan 109
15.6.3 May 23, 2011: Given Imaging Receives FDA Clearance For PillCam ESO 3 110
15.6.4 Mar 10, 2011: Given Imaging Unveils Updated FDA Clearance For PillCam SB Video Capsule 111
15.6.5 Oct 01, 2009: Given Imaging Receives FDA Nod For PillCam SB Video Capsules And Agile Patency Capsules For Use In Young Children 111
15.6.6 Oct 01, 2009: Given Imaging Receives FDA Nod For PillCam SB Video Capsules And Agile Patency Capsules For Use In Young Children 112
15.6.7 Feb 20, 2008: Given Imaging Announces PillCam COLON Approval In Israel 112
15.7 Clinical Trials 112
15.7.1 Oct 22, 2012: Given Imaging Reports New Studies On PillCam Colon 2 Presented At UEG Week In Amsterdam 112
15.7.2 May 22, 2012: New Studies Confirm Given Imaging’s PillCam COLON 2’s Feasibility In An Outpatient Setting 113
15.7.3 May 22, 2012: Given Imaging Announces Significant New Data On PillCam SB At DDW 114
15.7.4 May 22, 2012: New Studies Confirm Value Of Given Imaging’s PillCam SB In Managing Pediatric Patients With Inflammatory Bowel Disease 115
15.7.5 May 20, 2012: Study Shows That Bravo pH Monitoring Can Be Successfully Extended In Most Cases: Given Imaging 116
15.7.6 May 20, 2012: Data Show That Capsule Endoscopy Correlates With Gastroscopy Findings: Given Imaging 117
15.7.7 Jan 04, 2012: Given Imaging Provides Update On PillCam COLON 2 Pivotal Trial Enrollment 118
15.7.8 Nov 15, 2011: Given Imaging Initiates Pivotal Trial For PillCam COLON 2 In Japan 119
15.7.9 Nov 02, 2011: Given Imaging Announces New Studies Highlighting Value Of ManoScan AR In Patients With Incontinence 120
15.7.10 Nov 02, 2011: New Studies Confirm Use Of Bravo Wireless pH Monitoring For Assessment Of GERD: Given Imaging 120
15.7.11 Oct 31, 2011: Given Imaging Announces New Studies Validate Use Of PillCam SB To Detect And Monitor Crohn’s Disease 121
15.7.12 Oct 25, 2011: Given Imaging Announces New Studies Highlighting Value Of ManoScan High Resolution Manometry Testing For Conditions Resulting From Anti-Reflux Surgery 122
15.7.13 Oct 25, 2011: Given Imaging Announces New Studies Showing PillCam SB Can Detect And Monitor Small Bowel Crohn’s Disease 123
15.7.14 Oct 25, 2011: Given Imaging Announces Results From Multiple PillCam COLON Studies Presented At UEGW 2011 124
15.7.15 Oct 18, 2011: Given Imaging Announces New Study Shows Impact Of PillCam SB On Management Of Symptomatic IBD Cases 124
15.7.16 Jun 06, 2011: Given Imaging Initiates Trial For PillCam COLON 2 Capsule Endoscopy 125
15.7.17 May 11, 2011: Given Imaging Announces Positive Results From European Multicenter Study Of PillCam COLON 2 126
15.7.18 May 10, 2011: Given Imaging Announces New Clinical Studies Recommend Increased Use Of ManoScan High Resolution Manometry To Diagnose Motility Disorders 127
15.7.19 May 10, 2011: Given Imaging Announces New Presentations Emphasize Value Of PillCam Capsule Endoscopy In Patients With Gastrointestinal Bleeding At Digestive Disease Week 2011 128
15.7.20 May 09, 2011: Given Imaging Announces New Studies Confirm PillCam SB’s Role In Management Of Patients With Suspected And Known Crohn’s Disease 130
15.7.21 May 09, 2011: Given Imaging Announces New Data On Benefits Of Using Bravo Wireless pH Monitoring To Manage GERD 131
15.7.22 Jan 05, 2011: Given Imaging Initiates Study In US For PillCam COLON 2 Capsule Endoscopy 132
15.7.23 Apr 19, 2010: Given Imaging To Complete RD-300 Trial For PillCam Express Capsule Endoscopy Delivery System In Second Quarter Of 2010 132
15.7.24 Apr 13, 2010: Given Imaging To Complete Phase III Trial For PillCam COLON 2 In First Half Of 2010 132
15.7.25 Apr 12, 2010: Given Imaging To Complete Phase I Trial For PillCam SB2 Capsule In First Quarter Of 2011 133
15.8 Other Significant Developments 133
15.8.1 May 18, 2012: Given Imaging To Present New Studies At Digestive Disease Week 2012 133
15.8.2 May 03, 2011: Given Imaging To Present Product Lines At Digestive Disease Week 2011 133
15.8.3 Jan 20, 2009: Given Imaging Announces Expansion Of Distribution Agreement With FUJIFILM 134
15.8.4 Sep 25, 2008: Given Imaging CFO To Present At The JMP Securities And Maxim Group Growth Confrences 134
15.8.5 Sep 03, 2008: Given Imaging’s CEO To Present At The Morgan Stanley Conference 135
15.8.6 Feb 26, 2008: Given Imaging Wins FSS Contract With VA 135
16 Appendix 136
16.1 Research Methodology 137
16.2 Secondary Research 137
16.3 Primary Research 137
16.4 Models 138
16.5 Forecasts 138
16.6 Expert Panels 138
16.7 GlobalData Consulting 138
16.8 Currency Conversion 139
16.9 Contact Us 140
16.10 Disclaimer 140
【レポート販売概要】
■ タイトル:Given Imaging Ltd.:市場シェア分析■ 英文:Given Imaging Ltd. Market Share Analysis
■ 発行日:2013年3月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160638
■ 調査対象地域:グローバル
- アジピン酸(ADPA)の世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world adipic acid market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true insig …
- 有機ペットフードの世界市場2017-2021ABSTRACTAbout Organic Pet Food The global organic pet food market is growing at a high CAGR of 9.08% as this category is one of the emerging trends in the pet food industry owing to the increasing focus on pet health and wellness along with pet humanization. Many health issues like skin allergies, arthritis, brain aging, digestive disorders, and obesity are becoming common among pets, which is a s …
- 親水コロイドの世界市場:ゼラチン、キサンタン、カラゲーニン、アルジネート、寒天、ペクチン、グアー、イナゴマメ、アラビアガム、CMCThe hydrocolloids market is projected to grow at a CAGR of 5.80% from 2015 to reach a projected value of USD 7.56 Billion by 2020. The primary factors driving this market are the increasing health consciousness among the consumers and multi-functionality of hydrocolloids. The growing health consciousness among the consumers, especially in North America and Europe, drives the market at a high rate. …
- 化粧品成分の世界市場2017-2021:軟化剤、皮膜形成剤、モイスチャー、界面活性剤、単用添加剤、キャリア、パウダー、着色剤、増粘剤About Cosmetic Ingredients Cosmetic ingredients form the base chemicals for personal care products, which include soaps, shampoos, lotions, perfumes, and a variety of other products. Some cosmetics are not only used for beauty regimes, but they also serve as vital components of wellbeing. Some examples of vital cosmetics are toothpaste and sunscreens. Historically, there had been several amendment …
- フォームフィルシール(FFS)充填機の世界市場予測(~2020)The form-fill-seal market size is projected to grow from USD 16.99 Billion in 2015, to USD 21.55 Billion by 2020, at a CAGR of 4.87% from 2015 to 2020. The form-fill-seal market is increasing proportionally with the overall packaging equipment industry and growth in flexible packaging industry. The market is primarily driven by factors such as improving economic conditions of countries, technologi …
- 世界のプリンター市場動向(2014-2018)About Printers There are two main types of printers: Impact printers and non-impact printers. Impact printers produce text and images on paper when the print head of the printer strikes the paper physically. Non-impact printers like inkjet and laser printers do the same without actually striking the paper. While inkjet printers spray tiny drops of ink onto a paper, laser printers use cylindrical d …
- コハク酸の世界市場Succinic acid is an important intermediate chemical witnessing high demand. It is a building-block chemical for producing many specialty and commodity chemicals that are used in a wide range of applications, such as polymers, food, metals, pharmaceutical, coatings, fibers, solvents, lubricating oils, diesel fuel oxygenates, and cosmetics. The key application is 1, 4BDO, which accounted for ~17% in …
- 小売用自動化製品の世界市場:POSターミナル、キャッシュレジスター、レシートプリンタ、バーコードリーダー、キオスク/自動販売機、セルフレジ等The lucrative growth rate of the retail market in future is the major factor driving the Retail Automation market. Retail Automation has not only made the shopping experience easy and convenient for shoppers but has also enhanced their expectation for better quality of service. The stationary/fixed point of sale (POS) terminal is expected to have a higher market size as compared to the mobile/port …
- ネットワークエミュレータの世界市場予測(~2024年)Global network emulator market to grow at a CAGR of 8.1% during the forecast period The global network emulator market size to grow from USD 146 million in 2019 to USD 217 million by 2024, at a Compound Annual Growth Rate (CAGR) of 8.1% during 2019–2024. Rise of attacks and security breaches on networks, and the need for reduced downtime in networking are the major factors driving the network emul …
- 無人地上センサ(UGS)の世界市場2018-2022107 pages, November 2018 About this market The need for small, lightweight, and low power solutions in the military and aerospace industry is boosting the demand for nanotechnology and microelectromechanical systems (MEMS). This have encouraged manufacturers around the world to develop innovative miniaturized electronics. The low-cost sensors are less sophisticated and are mainly used for routine …
- 陸電の世界市場予測(~2024年)“The global shore power market is projected to grow at a CAGR of 13.3% from 2019 to 2024” The global shore power market is projected to reach USD 2.7 billion by 2024 from an estimated USD 1.4 billion in 2019, at a CAGR of 13.3% during the forecast period. Reduction of low-frequency noise and emissions at ports, a growing number of cruise liners in the shipping industry, and installation of retrofi …
- ボーディング・ブリッジ(搭乗橋)の世界市場2017-2021About Aerobridge Aerobridges were mainly introduced for passenger comfort. Passengers with disabilities face difficulty in climbing up and down the stairs laid on the apron to board a flight. These passengers usually require the help of crew to board and disembark from an aircraft. This slows down the boarding process and increases the layover time for flights causing delays. Use of aerobridges as …
- シリコーンの世界市場:タイプ別(エラストマー、流体、樹脂、ゲル、その他)、エンドユーザー別(建築、建設、輸送、パーソナルケア、消費財、エネルギー、電気、電子、紙、繊維、その他)The global silicone market was valued at $18.2 billion in 2018, and is projected to reach $91.4 billion by 2026, growing at a CAGR of 22.5% from 2019 to 2026. Silicone are polymers that are made up of siloxane. Siloxane is a chain of alternating silicon and oxygen atoms combined with carbon or hydrogen. It is a versatile material, owing to its exceptional chemical & mechanical properties, due to w …
- 高性能断熱材の世界市場:エアロゲル、セラミック繊維、グラスバブル、EPS、XPSThe high-performance insulation materials market is projected to reach USD 10.93 Billion by 2021, registering a CAGR of 11.2% between 2016 and 2021. The market is driven by the increased demand form the end-use applications such as oil & gas, industrial, construction, transportation, and paints & coatings, among others. Asia-Pacific region, with its growing economy and rapidly expanding commercial …
- 産業用エネルギー管理システム(IEMS)の世界市場:SCADA、PLC、DCS、エネルギー・プラットフォーム、メータデータ管理、EMIS、PLCS、DRMSIEMS is systematic collaboration of systems and practices to track, analyze, and plan the energy consumption usage in the industry. A high-quality and comprehensive IEMS forms business value by prioritizing the importance of energy as an essential business strategy, and by forming processes to monitor consumption and usage efficiency to achieve best practice in managing energy resources. The playi …